11 Oct DIABNEXT selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit
We are thrilled to announce that we are selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit, in Copenhagen, Denmark in November!
The 2017 Lyfebulb-Novo Nordisk Innovation Summit will recognize and empower international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management. This year the Lyfebulb-Novo Nordisk jury selected Laurent Nic
olas from DIABNEXT, the Diabetes automated self-management solution, as one of the Patient Entrepreneur finalists. Patient Entrepreneurs have a unique ability to create value-adding disease management solutions beyond therapy.
With the “patients first” vision, DIABNEXT helps both the healthcare professionals and the patients prevent and reduce diabetes-related complications without changing the patients’ existing devices and routines.
The Innovation Summit 2017 in Copenhagen will bring together Patient Entrepreneurs with venture capitalists, Lyfebulb founders, Novo Nordisk Device R&D leadership, researchers, and engineers to spotlight entrepreneurs’ efforts and ideas, and to facilitate professional discussion, direction, and inspiration.
Support us on November 6-8, 2017 in Copenhagen, Denmark.
Visit the website of the Lyfebulb-Novo Nordisk Innovation Summit 2017